Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing
    Meeting Abstract

    McIntyre, S. M.; Preston, W.; Walch, H.; Sigel, C.; Sharib, J.; Chen, W.; Lidsky, M. E.; Kundra, R.; Cercek, A.; Harding, J. J.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer
    Meeting Abstract

    Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Patient metabolic profiles defined by liver and muscle 18F-FDG PET avidity are independently associated with overall survival in gastric cancer
    Meeting Abstract

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L.; Schattner, M.; Janjigian, Y.; Ku, G.; Maron, S.; Schoder, H.; Larson, S.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Meeting Abstract

    Tao, A. J.; Ecker, B. L.; Janssen, Q.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Brennan, M. F.; Kingham, T. P.; Soares, K. C.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical benefit of sentinel lymph node biopsy nomograms for head and neck melanoma
    Meeting Abstract

    Drebin, H. M.; Kurtansky, N. R.; Cracchiolo, J. R.; Marchetti, M. A.; Bartlett, E. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Short- and long- term outcomes of minimally invasive vs open gastrectomy after neoadjuvant chemotherapy for gastric cancer
    Meeting Abstract

    Shimada, S.; Abate, M.; Drebin, H. M.; Fei, T.; Janjigian, Y.; Ku, G.; Tang, L.; Coit, D.; Strong, V. E.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Hepatic artery infusion chemotherapy compared to Y90 for treatment of unresectable colorectal liver metastases: A multi-institutional comparative study
    Meeting Abstract

    Saadat, L. V.; Chou, J.; Gonen, M.; Lee, R. M.; Maithel, S. K.; Li, A. Y.; Poultsides, G.; Aiken, T. J.; Schwartz, P. B.; Abbott, D. E.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Organ preservation, compliance and toxicity in rectal cancer patients treated with total neoadjuvant therapy: A post hoc analysis of the of the OPRA phase II trial
    Meeting Abstract

    Verheij, F. S.; Omer, D. M.; Lin, S. T.; Yuval, J. B.; Thompson, H. M.; Kim, J.; Valdivieso, S. C.; Qin, L. X.; Wu, A. J.; Saltz, L. B.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage
    Meeting Abstract

    Sharib, J.; Liu, A.; McIntyre, S.; Rhodin, K. E.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; Abou-Alfa, G. K.; Soares, K. C.; Wei, A. C.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save